02033-5/asset/e4c9417f-3cd1-4983-b1a9-6c6b1c8112ee/main.assets/gr2_lrg.jpg)
ly3437943 retatrutide triple agonist glp-1 gip glucagon LY3437943, a novel GIP, GLP-1, and receptor in people with type 2 diabetes: a phase 1b, multicentre, double-blind, placebo-controlled, randomised, multiple-ascending dose trial Retatrutide (LY3437943): Mechanism of Action
Description
ISSN 0367-8377
Effects of glucagon-like peptide-1 on the reproductive axis in healthy men
What are Zepbound, Semaglutide GLP-1, and Wegovy approved for
In the Synapse database, you can keep abreast of the latest research and development advances in drugs, targets, indications, organizations, etc., anywhere and anytime, on a daily or weekly basis
When paired with healthy habits and personalized support, they can lead to real, lasting progress
